LAFTI probiotic line lands at Lallemand
This article was originally published in The Tan Sheet
Executive Summary
Institut Rosell-Lallemand acquires the LAFTI probiotics line from Dutch ingredient giant DSM. The subsidiary of Canadian company Lallemand said March 8 it will expand LAFTI's dietary supplement applications into sports nutrition and recovery. Current LAFTI applications include Attune Foods' Attune Probiotic Wellness Bars (1"The Tan Sheet" April 2, 2007). DSM retains a license to LAFTI's dairy business, consistent with the firm's food- and beverage-based probiotic application strategy, Lallemand said
You may also be interested in...
Brand New Brands Introduces Incubation To Functional Foods Market
Brand New Brands is bringing the incubator business model into the functional foods market with its four spinout companies, which co-founder William Rosenzweig says will continue to be "nurtured" with innovations in product quality
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.